Bought back in, I only held a few hundred shares f
Post# of 148176
(Total Views: 635)
Posted On: 12/09/2020 2:39:13 PM
Bought back in, I only held a few hundred shares from before. Not enough to sift IH. A bad case of FOMO and I'm back!
It will be interested with all these new investors!!
On the one hand: They have NO idea how good this drug is!!!
On the other hand: They probably have never witnessed the communication style of a CEO like this!
I hope the moderator starts the call like this: "New Investors, I'd like to introduce you to our CEO with a manufacturing background who can filibuster with the best of them! His secret: We pump one of his lungs with oxygen so he never has to take a breath to let anyone else speak and no matter how important time is, there is always an opportunity to tell you how the story of how he bought pro-140, no matter what question he's answering or opportunity missed to educate about the current situation!" ;-P
But on a curious note I would like to know why they still call it pro-140? Isn't 2 names enough? I mean why use the opportunity to educate the masses that it's a monoclonal antibody when you can make it sound like the nickname of a retired offensive lineman! (?)
For the record I think NP is a really nice man who works immensely hard. Other than not releasing the data months ago to get real publicity (proactive is cool and all) or partnering with companies to fill trials he's come a long way. He's great at not diluting shares, and making sure he's a millionaire millions of times over regardless of whether we end up in the covid space to fund other trials and start earning income or not.
As an optimist myself, I think his greatest hinderance has been being too optimistic about getting 400 patients without partnership.
Although I hate to use a Trump line "It looks like we are rounding the corner!" In all seriousness, it really does! Glad to be back in!
It will be interested with all these new investors!!
On the one hand: They have NO idea how good this drug is!!!
On the other hand: They probably have never witnessed the communication style of a CEO like this!
I hope the moderator starts the call like this: "New Investors, I'd like to introduce you to our CEO with a manufacturing background who can filibuster with the best of them! His secret: We pump one of his lungs with oxygen so he never has to take a breath to let anyone else speak and no matter how important time is, there is always an opportunity to tell you how the story of how he bought pro-140, no matter what question he's answering or opportunity missed to educate about the current situation!" ;-P
But on a curious note I would like to know why they still call it pro-140? Isn't 2 names enough? I mean why use the opportunity to educate the masses that it's a monoclonal antibody when you can make it sound like the nickname of a retired offensive lineman! (?)
For the record I think NP is a really nice man who works immensely hard. Other than not releasing the data months ago to get real publicity (proactive is cool and all) or partnering with companies to fill trials he's come a long way. He's great at not diluting shares, and making sure he's a millionaire millions of times over regardless of whether we end up in the covid space to fund other trials and start earning income or not.
As an optimist myself, I think his greatest hinderance has been being too optimistic about getting 400 patients without partnership. Although I hate to use a Trump line "It looks like we are rounding the corner!" In all seriousness, it really does! Glad to be back in!
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼